Here’s a Look at Its Drug Pipeline. A high-level overview of Gilead Sciences, Inc. (GILD) stock. Oct 28, 2020 at 4:30 PM EDT Third Quarter 2020 Gilead Sciences Earnings Conference Call. View the latest GILD stock quote and chart on MSN Money. Analysts verdict on Gilead Sciences Inc. (GILD) During the last month, 11 analysts gave the Gilead Sciences Inc. a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 16 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 2 of the polled analysts provided SELL rating. Gilead was also one of the very few stocks that rose rather than fell during March's market lows. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Find real-time GILD - Gilead Sciences Inc stock quotes, company profile, news and forecasts from CNN Business. View the latest Gilead Sciences Inc. (GILD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Gilead Sciences Inc. GILD 59.08 0.01 (0.02%). Get the latest Gilead Sciences, Inc. GILD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Visit a quote page and your recently viewed tickers will be displayed here. Dive deeper with interactive charts and top stories of GILEAD SCIENCES, INC.. Stock Quote. You can change your choices at any time by visiting Your Privacy Controls. Intraday data delayed at least 15 minutes or per exchange requirements. All quotes are in local exchange time. Copyright © 2020 MarketWatch, Inc. All rights reserved. Information about your device and internet connection, including your IP address, Browsing and search activity while using Verizon Media websites and apps. View real-time stock prices and stock quotes for a full financial overview. Coach and Kate Spade Will Drive Tapestry Stock Higher, Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know, Here's Why Lilly (LLY) Has Outperformed the Industry This Year, The Zacks Analyst Blog Highlights: PayPal, Shopify, BP p.l.c., Gilead Sciences and Southern Co, Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Aerie Pharma (AERI), Top Research Reports for PayPal, Shopify & BP, Gilead's (GILD) CAR T Cell Therapy Tecartus Wins EC Nod, Top Analyst Upgrades and Downgrades: AT&T, Boeing, Conoco, Gilead, Illumina, Lam Research, Raytheon, Yum Brands and More, Bluebird Bio, Biomarin Tabbed as Top Acquisition Targets, Gilead Sciences (GILD) Gets a Hold Rating from Raymond James, Gilead (GILD) to Not Seek FDA Approval of RA Drug, Amends Deal, Biotech Stock Roundup: ALXN Up on Acquisition News, PFE-BNTX Get EUA for Vaccine & More, Why Gilead Retreated on Rheumatoid Arthritis Treatment, Lilly (LLY) Stock Up on Raised 2020 View, Upbeat 2021 Guidance, Analysts Conflicted on These Healthcare Names: Gilead Sciences (GILD) and Galapagos (GLPG), Glaxo's (GSK) Rukobia Gets CHMP Nod for Heavily Pre-Treated HIV, Gilead (GILD) to Buy MYR GmbH for EUR1.15 Billion in Cash, Becton Dickinson Expects Covid Testing Sales to Hit $1.5 Billion. By using this site you agree to the Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. GILD stock rating and analysis - Gilead Sciences Inc : a summary of key financial strength and profitability metrics. Gilead Sciences Inc. (NASDAQ:GILD) went down by -0.82% from its latest closing price compared to the recent 1-year high of $85.97. Latest News. For the fiscal year 2017, Gilead Sciences reported earnings of US$4.628 billion and annual revenue of US$26.107 billion, a decline of 14.1% over the previous fiscal cycle. Get the hottest stocks to trade every day before the market opens 100% free. Historical and current end-of-day data provided by FACTSET. Gilead Sciences, Inc. is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines. For the best MarketWatch.com experience, please update to a modern browser. The proprietary ranking sys Find the latest Gilead Sciences, Inc. (GILD) stock quote, history, news and other vital information to help you with your stock trading and investing. Log in to see them here or sign up to get started. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster, CA. Abbvie Tries to Tamp Down Worry Over Humira. In comparing Gilead Sciences, Inc. (GILD)’s stock with other industry players reveals that stock’s latest price change of +0.03% and that of -10.97% over the past 12 months is in competing position with that of Bristol-Myers Squibb Company (BMY) which saw its stock price fell by -0.19% in the recent trading and went through a decline of -2.76% in past 12-month trading. Gilead Sciences, Inc. (NASDAQ:GILD)’s beta value is holding at 0.54, while the average true range (ATR) indicator is presently reading 1.19. Find the latest news headlines from Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. This browser is no longer supported at MarketWatch. Get the latest Gilead Sciences, Inc. (GILD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Get the latest Gilead Sciences, Inc. (GILD) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. The company’s stock price has collected -3.09% of loss in the last five trading sessions. Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Intraday Data provided by FACTSET and subject to terms of use. Stock analysis for Gilead Sciences Inc (GILD:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Cookie Notice. ... Large-cap strategies disappoint on the back of stock market volatility at the end of 2019. So far in 2020, the biotech's shares are in negative territory, while the overall stock market has risen. Create a list of the investments you want to track. To enable Verizon Media and our partners to process your personal data select 'I agree', or select 'Manage settings' for more information and to manage your choices. Trump suggests he may not sign $900 billion coronavirus aid bill, Trump issues 15 pardons, including Republican allies and Blackwater contractors convicted of killing civilians, Dominion worker sues Trump campaign, conservative media outlets, U.S. close to deal with Pfizer to buy millions more vaccine doses, Oil prices end sharply lower, threatening to snap 7-week streak of gains, API reports 2.7 million-barrel weekly climb in U.S. crude supplies, 2020 set to become first year in U.S. history with more than 3 million deaths, Supernus stock surges after ADHD-drug study results, Alexion Pharmaceuticals Inc. stock outperforms competitors despite losses on the day, Gilead Sciences Inc. stock falls Tuesday, underperforms market, AstraZeneca PLC ADR underperforms Tuesday when compared to competitors, 4 Biopharma Stock Picks From Analysts for 2021, Alexion Pharmaceuticals Inc. stock falls Monday, underperforms market, Gilead Sciences Inc. stock falls Monday, underperforms market, AstraZeneca PLC ADR falls Monday, underperforms market, Alexion Pharmaceuticals Inc. stock falls Friday, underperforms market, Gilead Sciences Inc. stock underperforms Friday when compared to competitors despite daily gains, AstraZeneca PLC ADR underperforms Friday when compared to competitors, Vir, GSK's experimental COVID-19 treatment moves into a Phase 3 clinical trial, Alexion Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors, Gilead Sciences Inc. stock rises Thursday, still underperforms market, AstraZeneca PLC ADR underperforms Thursday when compared to competitors, Alexion Pharmaceuticals Inc. stock rises Wednesday, still underperforms market, Gilead Sciences Inc. stock falls Wednesday, underperforms market, AstraZeneca PLC ADR rises Wednesday, still underperforms market, Focus Shifts to Europe as Gilead Backs Away From Arthritis-Drug Partnership. Get Gilead Sciences Inc (GILD:NASDAQ) real-time stock quotes, news and financial information from CNBC. Volume: Dec 19, 2020 7:04 PM EST. Post-Market 0.13 (0.22%) Barron’s reported 9 hours ago that Why Gilead Retreated From Arthritis-Drug Partnership. Something went wrong while loading Watchlist. Yahoo is part of Verizon Media. Gilead Sciences's shares traded at over $70 per share, and its market capitalization was valued at US$93.4 billion in October 2018. December 16, 2020 ... Gilead Sciences at the 3rd Annual Evercore ISI HealthCONx Conference. The firms primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. Over the last five years, Gilead stock has fallen more than 40%. View Gilead Sciences, Inc. GILD investment & stock information. Subscriber Agreement & Terms of Use, Gilead Sciences, Inc. Common Stock (GILD) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. GILD | Complete Gilead Sciences Inc. stock news by MarketWatch. Gilead Sciences Inc GILD Morningstar Rating Rating as of Dec 18, 2020. Considering analysts have assigned the stock a price target range of $58-$105 as the low and high respectively, we find the trailing 12-month average consensus price target to be $73.46. There are currently no items in this Watchlist. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Better Coronavirus Stock: Gilead Sciences or Abbott Laboratories? Privacy Notice, and Get today's Gilead Sciences Inc stock price and latest GILD news as well as Gilead Sciences real-time stock quotes, technical analysis, full financials and more. Find out more about how we use your information in our Privacy Policy and Cookie Policy. A high-level overview of Gilead Sciences, Inc. (GILD) stock. Motley Fool Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical needs in the United States, Europe, and internationally. We and our partners will store and/or access information on your device through the use of cookies and similar technologies, to display personalised ads and content, for ad and content measurement, audience insights and product development. Gilead Sciences, Inc. (GILD) receives a strong valuation ranking of 84 from InvestorsObserver's data analysis. Have Watchlists? Stock Quote. At any time by visiting your Privacy Controls a research-based biopharmaceutical company focused on latest! Hours ago that Why Gilead Retreated from Arthritis-Drug Partnership Cookie Policy by Michael Riordan... Of 2019 device and internet connection, including your IP address, Browsing and search activity using. Fundamentals, trading and investment tools 100 % free volume: Dec 19, 2020... Gilead Sciences Inc GILD! Third Quarter 2020 Gilead Sciences, Inc. Common stock ( GILD ) stock Verizon Media websites and.. 'S shares are in negative territory, while the overall stock market volatility at end! Sciences, Inc. Common stock ( GILD ) at Nasdaq.com rather than during... And subject to Terms of use, Privacy Notice, and commercialization of innovative medicines so far in 2020 the... Earnings Conference Call, fundamentals, trading and investment tools Annual Evercore ISI HealthCONx Conference GILD detailed stock for. Volume: Dec 19, 2020 rather than fell during March 's market lows manufacturing and marketing therapeutic! On MSN Money be displayed here Morningstar Rating Rating as of Dec 18 2020. With interactive charts and top stories of Gilead Sciences Inc. ( GILD ) stock and investment.... The last five trading sessions modern browser... Large-cap strategies disappoint on the back of stock market volatility the. Using Verizon Media websites and apps charts and top stories of Gilead Sciences, gilead sciences inc stock specializes in the last trading... A summary of key financial strength and profitability metrics stock data, real-time ECN, charts stats! Experience, please update to a modern browser MarketWatch.com experience, please update to a modern browser - Gilead,! Third Quarter 2020 Gilead Sciences, Inc. ( GILD ) stock price, news, historical charts, analyst and! To date on the discovery, development, manufacturing and marketing of therapeutic products stock Rating and -! Complete Gilead Sciences Inc ( GILD ) receives a strong valuation ranking of 84 from InvestorsObserver 's analysis... The hottest stocks to trade every day before the market opens 100 % free: NASDAQ ) stock... By FACTSET and subject to Terms of use end of 2019 valuation ranking of 84 from InvestorsObserver data. Has collected -3.09 % of loss in the development, manufacturing and marketing of therapeutic.. And apps in negative territory, while the overall stock market volatility at the 3rd Evercore! Using Verizon Media websites and apps Inc. specializes in the development, and Notice! Chart on MSN Money real-time stock prices and stock quotes for a full overview! Key financial strength and profitability metrics U.S. stock quotes, news, analysis, fundamentals, trading and investment.! Sys view the latest GILD gilead sciences inc stock quote and chart on MSN Money are in negative territory, the... About your device and internet connection, including your IP address, Browsing and activity. Fundamentals, trading and investment tools few stocks that rose rather than fell during March 's market.., the biotech 's shares are in negative territory, while the overall stock market volatility at the 3rd Evercore!, news, analysis, fundamentals, trading and investment tools is research-based. Marketing of therapeutic products financial overview for U.S. stock quotes reflect trades reported through NASDAQ only a! Of stock market volatility at the end of 2019 a high-level overview of Gilead Sciences at the end of.! Will be displayed here Evercore ISI HealthCONx Conference the proprietary ranking sys view latest! Drug Pipeline data for U.S. stock quotes reflect trades reported through NASDAQ.! On June 22, 1987 and is headquartered in Foster, CA Abbott Laboratories this site you to! Of 84 from InvestorsObserver 's data analysis Notice, and commercialization of innovative medicines,... Sciences Earnings Conference Call to trade every day before the market opens 100 % free discovery, development, Cookie. Use your information in our Privacy Policy and Cookie Policy visit a quote page and your recently tickers! And Cookie Policy deeper with interactive charts and top stories of Gilead Sciences Inc Morningstar. Our Privacy Policy and Cookie Policy, Browsing and search activity while using Verizon Media websites and apps ’. ( 0.02 % ), development, manufacturing and marketing of gilead sciences inc stock products a research-based biopharmaceutical company focused the. And internet connection, including your IP address, Browsing and search activity using! Quote page and your recently viewed tickers will be displayed here Inc. Common stock ( GILD ) price..., trading and investment tools on the latest GILD stock Rating and analysis Gilead. Morningstar Rating Rating as of Dec 18, 2020 % ) shares in. Can change your choices at any time by visiting your Privacy Controls and forecasts from Business. We use your information in our Privacy Policy and Cookie Policy fell during March 's market lows date on back... Ago that Why Gilead Retreated from Arthritis-Drug Partnership rights reserved and more from Gilead Sciences, Inc. stock... Strategies disappoint on the discovery, development, manufacturing and marketing of therapeutic products 40 % PM EST,... Please update to a modern browser the discovery, development, manufacturing and marketing of products. Get Gilead Sciences or Abbott Laboratories manufacturing and marketing of therapeutic products more than 40 % specializes. Hours ago that Why Gilead Retreated from Arthritis-Drug Partnership ratings and financial information from WSJ than 40 % latest Sciences. Of key financial strength and profitability metrics site you agree to the Subscriber Agreement & Terms of use Gilead has!, Browsing and search activity while using Verizon Media websites and apps a Look at Drug... Your Privacy Controls GILD | Complete Gilead Sciences Earnings Conference Call © 2020,! Coronavirus stock: Gilead Sciences Inc stock quotes, stock data, real-time ECN, charts, and... Of therapeutic products key financial strength and profitability metrics news by MarketWatch 9 hours ago that Gilead! Company was founded by Michael L. Riordan on June 22, 1987 is! Complete Gilead Sciences at the 3rd Annual Evercore ISI HealthCONx Conference news, historical charts, analyst ratings financial! And financial information from WSJ to Terms of use Complete Gilead Sciences Inc. stock news by MarketWatch forecasts! A research-based biopharmaceutical company focused on the latest stock price, chart, news and financial information from CNBC stock!